GlucoSet Overview

Founded 2011
Status Acquired/​Merged
Employees 11
Latest Deal Type Buyout/​LBO
Investors 3

GlucoSet General Information


Developer of health monitoring system designed to reduce harmful hypoglycemia. The company's real-time intravascular blood glucose monitoring system delivers continuous and accurate information on the patient's blood glucose level, enabling normalization of glucose levels, without the risk of sudden and dangerously low glucose levels.

Contact Information

Ownership Status
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Distributors (Healthcare)
Parent Company
Primary Office
  • Sluppenvegen 6
  • 7037 Trondheim
  • Norway
+47 977 00 000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GlucoSet Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Buyout/LBO Completed Pre-Clinical Trials
2. Grant 24-Feb-2016 00.000 Completed Pre-Clinical Trials
1. Grant 17-Oct-2014 $24.8K Completed Pre-Clinical Trials

GlucoSet Executive Team (5)

Name Title Board Seat Contact Info
Nicolas Elvemo Chief Executive Officer
Lukas Scherer Chief Technology Officer
Parvinder Dhillon Chief Technology Officer
Dag Hjelme Co-Founder

1 Former Executive

GlucoSet Board Members (5)

Name Representing Role Since
Erik Fuglseth Ph.D Self Board Member 000 0000
Jan Sollid Self Chairman 000 0000
Jørgen Nilsen Televenture Board Member 000 0000
Kjell Ingebrigtsen Ph.D Self Board Member 000 0000
Reinold Ellingsen Ph.D GlucoSet Board Member 000 0000

Ready to get started?

Request a free trial